MELIES Business Angels
ZAC Cambacères CS 50948 10 Place Françoise Héri tier, Montpellier, Hérault, 34967, France
Overview
MELIES Business Angels is an association that brings together more than one hundred investors in order to finance and support companies in the Languedoc-Roussillon region with strong growth potential. MELIES BA was labeled in 2006 by the Ministry of SMEs / SMIs and in 2014 by iSource. In 2016, the Toulouse-based Capitole Angels and MELIES Business Angels network together created a new federative structure
- Total investments
- 3
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 1
Investment portfolio
- Drone Geofencing
Participated · Equity · Dec 2023
Drone Geofencing has built a fleet-management solution that supervises multi-model drones from a control center, allowing individual missions or swarm operations and supporting point-to-point 1 Gbps links over 10 km. The system and its swarm guidance algorithms were co-developed with CNRS laboratories and the Italian Aerospace Research Center. The solution is compatible with international low-altitude airspace regulations and targets operators managing fleets of more than 10 drones for parcel delivery, surveillance, preventive maintenance of industrial infrastructure, and military and civil security missions. The company reports about fifty customers using its products. The newly raised funds will be used primarily to deliver first systems, industrialize the solution, and commercialize in Europe first, then more broadly. Drone Geofencing was founded in August 2019, is based in Nîmes, was incubated at BIC Innov'Up and TTM Factory, and received a Deeptech label from Bpifrance in 2021.
- Deepbloo
Participated · Equity · Jan 2021
Deepbloo operates a platform for energy-sector business development that collects public tenders and applies Natural Language Processing to analyse unstructured data and surface qualified opportunities for professionals. The service provides clients with a tailored portfolio of opportunities plus market-monitoring and commercial intelligence tools. The company reports 2,500 active professionals on the platform, about 400,000 tenders available in real time, and 1,000–2,000 tenders collected daily. Management says it already generates roughly 80% of its sales internationally and plans to accelerate international commercialisation. Proceeds from the recent financing will be used to deepen the platform's intelligent identification and analysis of unstructured tender data and to speed up commercial roll-out. Deepbloo was founded in late 2018 and is incubated at the Montpellier Business Innovation Center, employing about ten people across Montpellier and Bordeaux.
- Wefight
Participated · Equity · Jul 2019
Wefight has developed Vik, a virtual assistant and a framework used to build more than a dozen condition-specific apps (depression, asthma, multiple cancers, etc.). The company builds its technology in-house, including natural-language processing and the app framework, and its content is written by professional pharmacists. Vik interprets patient questions, searches a knowledge database, and relays neutral, informative answers so users need not wait for their next doctor appointment. More than 400,000 people have used the service, Vik has delivered 5 million answers, and Wefight employs about 70 people. The company finances new apps by working with pharmaceutical companies as top-of-funnel content partners while retaining editorial independence. Following an $11.6 million (€10 million) funding round, Wefight plans international expansion with a new office in Berlin and will hire local health professionals and partner with patient organizations in each new market. WeFight has developed Vik, a virtual assistant that converses via instant messaging, web chat and SMS to support patients with cancer and other chronic diseases. Contents are written by health professionals and Vik provides advice, daily support, and a channel for patients to share experiences and learn to manage their conditions. Clients include hospitals, pharmaceutical companies and insurers, and the company says Vik is available for conditions including breast cancer, asthma, migraine and depression. WeFight aims to empower patients, prevent relapses, and increase efficiency for healthcare teams by freeing caregivers to focus on complex cases. Founded in 2017 by Benoît Brouard and Pierre Nectoux, the company was a winner of the EIT Health France Innovation Journey pitch contest. With €1.8 million in new funding, WeFight plans to accelerate development of Vik to cover more than 30 diseases by 2020 and to expand into European and North American markets.
Team
Gilles Roche
President
LinkedIn